Acelyrin | 10-Q: Q3 2024 Earnings Report
Acelyrin | 8-K: ACELYRIN, INC. Reports Third Quarter 2024 Financial Results and Recent Highlights
Acelyrin | 10-Q: Q2 2024 Earnings Report
Acelyrin | 8-K: ACELYRIN, INC. Announces Positive Phase 3 Data for Izokibep in Hidradenitis Suppurativa; Focuses Strategy on Lonigutamab and Reports Second Quarter 2024 Financial Results
Acelyrin | 10-Q: Q1 2024 Earnings Report
Acelyrin | 10-K: FY2023 Annual Report
Acelyrin | 10-Q: Quarterly report
Acelyrin | 8-K: ACELYRIN, INC. Reports Third Quarter 2023 Financial Results and Recent Highlights
Acelyrin | 8-K: ACELYRIN, INC. Reports Second Quarter 2023 Financial Results and Recent Highlights
Acelyrin | 10-Q: Quarterly report
Acelyrin | 8-K: ACELYRIN, INC. Reports First Quarter 2023 Financial Results and Recent Highlights
Acelyrin | 10-Q: Quarterly report
Unlock the Full List